Bayer/Roche Consumer Unit Will Focus On Rx-To-OTC Switch Opportunities
This article was originally published in The Tan Sheet
Executive Summary
Bayer expects the addition of Roche Consumer Health to bolster the firm's ability to handle future Rx-to-OTC switches
You may also be interested in...
OTC M&A Trend May Be Result Of Too Many Large Players At The Top – Panel
A lack of competitive global scale may be one factor fueling the divestiture of OTC units by larger pharma companies
OTC M&A Trend May Be Result Of Too Many Large Players At The Top – Panel
A lack of competitive global scale may be one factor fueling the divestiture of OTC units by larger pharma companies
OTC M&A Trend May Be Result Of Too Many Large Players At The Top – Panel
A lack of competitive global scale may be one factor fueling the divestiture of OTC units by larger pharma companies